Medical News

RSS

Health groups urge restrictions on tobacco additives

Following five days of deliberations aimed at fleshing-out the so-called Framework Convention for Tobacco Control, delegates on Saturday approved a proposal to limit the use of tobacco additives, which critics say improve the flavor of cigarettes, encouraging consumers to smoke more, Reuters reports.

23 Nov 2010

Medicare making changes to acknowledge telemedicine's growing use

American Medical News: Through teleconferencing technology, doctors are able to treat patients who live far away without access to a specialist. "Nationwide, telemedicine increasingly is being used to bridge gaps in access to care in rural and other medically underserved communities that have a hard time recruiting physicians.

23 Nov 2010

Arthritis Foundation, Covidien join forces to help Americans suffering from osteoarthritis

The Arthritis Foundation and Covidien have joined forces to help advance awareness and support for millions of people suffering from osteoarthritis in the United States.

23 Nov 2010

New method to reverse age-related decline in vision

Elderly adults can improve their vision with perceptual training, according to a study from the University of California, Riverside and Boston University that has implications for the health and mobility of senior citizens.

23 Nov 2010

Debt woes keep harsh guidelines aloft, forge unlikely alliances

A controversial debt panel's advice was initially thought to be heading nowhere fast, but a surprisingly broad consensus that action must be taken to avoid a debt crisis has kept negotiators at the table and given the recommendations unexpected buoyancy, The Washington Post reports.

23 Nov 2010

Apricus files protocol of PrevOnco Phase 3 clinical trial for FDA SPA program

Apricus Biosciences, Inc., today announced that it has filed the protocol for a proposed Phase 3 clinical trial of PrevOnco, its proprietary treatment for hepatocellular carcinoma (liver cancer), with the U.S. Food and Drug Administration (FDA).

23 Nov 2010

Grant adds PTR-35 360° vertical rotator to bio product range

Grant Instruments, a world-renowned supplier of scientific, life sciences and data acquisition products, has introduced a variable speed, variable angle 360º vertical rotator combining three mixing functions - vertical rotation, reciprocation and vibration - into one easy-to-use and highly versatile compact unit.

23 Nov 2010

USPTO issues patent for neurotherapeutic pharmaceutical formulation

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that the U.S. Patent & Trademark Office has issued U.S. Patent 7,833,998 entitled, Oral Neurotherapeutic Cephalosporin Sulfoxide and Sulfone-containing Compositions.

23 Nov 2010

Mergers among hospitals and doctors spur consumer concerns, The NY Times reports

The New York Times: "[E]ight months into the new law there is a growing frenzy of mergers involving hospitals, clinics and doctor groups eager to share costs and savings, and cash in on the incentives [provided in the overhaul]. They, in turn, have deployed a small army of lawyers and lobbyists trying to persuade the Obama administration to relax or waive a body of older laws intended to thwart health care monopolies, and to protect against shoddy care and fraudulent billing of patients or Medicare.

23 Nov 2010

BioCancell raises $5.1 million by excess demand in public offering

Success for BioCancell Therapeutics Inc. Excess demand in BioCancell's public offering of shares and warrants generated immediate proceeds of $5.1 million, 18% above its stated minimal fundraising goal of $4.3 million.

23 Nov 2010

Dangers of excess fructose

More and more people have become aware of the dangers of excessive fructose in diet. A new review on fructose in an upcoming issue of the Journal of the American Society of Nephrology (JASN) indicates just how dangerous this simple sugar may be.

23 Nov 2010

First African tapped as new head of U.N. population fund

U.N. Secretary-General Ban Ki-moon announced on Friday that former Nigerian Health Minister Babatunde Osotimehin has been appointed to head to head the U.N. Population Fund (UNFPA), the U.K. Press Association reports.

22 Nov 2010

Otix Global announces shareholder approval for merger with William Demant Holding

Otix Global, Inc. announced today that its shareholders voted to approve the Agreement and Plan of Merger dated September 13, 2010 between Otix and William Demant Holding A/S (WDH), as subsequently amended on October 6, 2010 and October 14, 2010 (the merger agreement).

22 Nov 2010

Omega announces expiration of Senior Notes due 2020

Omega Healthcare Investors, Inc. announced today that its offer to exchange any and all of its outstanding $200 million of 7½% Senior Notes due 2020 that were issued in a private placement in February 2010, for $200 million of 7½% Senior Notes due 2020 that have been registered under the Securities Act of 1933, as amended, expired at 5:00 p.m., New York City time, on Monday, November 22, 2010.

22 Nov 2010

New law's health insurance regulations could mean rebates for consumers

Kaiser Health News staff writer Julie Appleby reports: "Millions of Americans might be eligible for rebates starting in 2012 under regulations released Monday detailing the health care law's requirement that insurers spend at least 80 percent of their revenue on direct medical care.

22 Nov 2010

Medtronic enters merger agreement to acquire Ardian

Medtronic, Inc. and privately-held Ardian, Inc. announced today that they have entered into a merger agreement whereby Medtronic will acquire Ardian.

22 Nov 2010

Soligenix receives U.S patent for modified immunogen in RiVax vaccine

Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent and Trademark Office has granted patent #7,829,668, entitled Compositions and methods for modifying toxic effects of proteinaceous compounds.

22 Nov 2010

Transparent develops new medium for Cell-able array kit to maintain metabolite activity

Transparent Inc. announced that it has developed a more advanced medium for Cell-able, a human hepatocyte array kit that has the potential to reduce drug development costs and time-to-market for pharmaceutical companies. Transparent first introduced Cell-able in the United States a year ago.

22 Nov 2010

Pope says condoms are justified in some cases to prevent HIV infection

Pope Benedict XVI says in a new book that condoms can be justified for male prostitutes seeking to stop the spread of HIV, a stunning comment for a church criticized for its opposition to condoms and for a pontiff who has blamed them for making the AIDS crisis worse, the Associated Press/Washington Post reports.

22 Nov 2010

Winston announces Phase II study results of Dolorac for chronic migraine at Lazard Conference

Winston Pharmaceuticals, Inc. a specialty pharmaceutical company focused on developing and commercializing novel pain management therapies, announced the results of its Phase II study on its patented Dolorac Nasal Solution (doxepin 0.4%) for prophylaxis of chronic migraine at the Lazard Capital Markets 7th Annual Healthcare Conference in New York.

22 Nov 2010